Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves expanded indications for Ilaris for three rare diseases

September 23, 2016Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients:

Post navigation

← FDA approves Amjevita, a biosimilar to Humira Waymouth Farms, Inc. Issues an Allergy Alert on Undeclared Pecans, Walnuts, Milk and Soy in Good Sense Cranberries ‘N More →
Proudly powered by WordPress